Updated:
Accretive
Accretive operates from New York, founded and led by J. Michael Cline alongside Partner Caroline Cline.
Accretive
Accretive operates from New York, founded and led by J. Michael Cline alongside Partner Caroline Cline. The firm identifies overlooked structural shifts in large industries and then builds a company purpose-fit to capture the value edge. It emphasizes company design and long-term ownership, investing its own capital rather than managing outside limited-partner commitments. The strategy bypasses traditional fund structures and conventional deal sourcing. Accretive develops proprietary market insights, then designs a customer-centric business model, recruits an executive team, and provides permanent capital. The portfolio spans digital health, insurance, education, and media. Confirmed outcomes include Fandango, the dominant U.S. online movie-ticketing platform serving 16,000 screens, later acquired by Comcast; R1, which pioneered end-to-end revenue-cycle management for large hospitals and went public; and Accolade, a health-assistant platform for employers that also reached public markets. Other companies include Insureon, the largest online small-business insurance marketplace, acquired by Hub International, and Accumen, a laboratory-operations outsourcer acquired by Arsenal Capital. The firm lists four named principals beyond the Clines — General Counsel Anne-Marie Shelley and CFO Tony Shum — but does not disclose total headcount. It maintains offices at 18 East 50th Street and 112 West 34th Street in Midtown Manhattan. No formal philanthropic vehicle or separate club structure appears publicly attached to the Accretive name. The structural distinction is the absence of a fund. Accretive does not raise blind pools, charge management fees on committed capital, or operate under a five-to-seven-year liquidation clock. It holds companies indefinitely, allowing business models to mature well past a typical private-equity exit window. That architecture gives it a governance posture closer to a permanent holding company than a private-equity manager — with the patience to build industry leaders over decades.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New York
Corporate office
18 E. 50th Street, New York, NY 10022
Additional offices
112 W. 34th Street, Floor 18, New York, NY 10112
Principals
J. Michael Cline
Founder and Managing Partner
Caroline Cline
Partner
Anne-Marie Shelley
General Counsel
Tony Shum
Chief Financial Officer
Sector focus
Frequently asked questions
Who runs investment and company-building decisions at Accretive?
Founder and Managing Partner J. Michael Cline leads all company-creation activity. Caroline Cline serves as Partner, and the firm operates with a small senior team that includes General Counsel Anne-Marie Shelley and CFO Tony Shum. The firm does not publicly describe an investment committee; decision-making appears concentrated in the founder's office, consistent with a self-funded, build-from-scratch model.
Is Accretive structured as a private equity fund or a holding company?
Accretive functions as a permanent-capital company builder, not a traditional private equity fund. It does not raise blind-pool funds from limited partners, does not operate under a fixed fund life, and invests its own capital. This structure allows indefinite hold periods and removes the liquidity pressure that shapes typical PE portfolio behavior.
How does Accretive source opportunities?
The firm does not source existing companies for acquisition. It identifies an industry domain, develops a proprietary thesis about an unmet customer need, designs a business model to capture the value gap, and then recruits an executive team to build the company. Deal flow is entirely internal and thesis-driven, not auction-based or intermediary-dependent.
Does Accretive take outside capital or participate in fund commitments alongside other investors?
Accretive states it invests its own capital to create industry leaders. There is no public evidence that the firm accepts outside LP commitments, co-invests alongside external GPs, or participates in third-party fund structures. It operates as a self-funded entity, though individual portfolio companies may later raise external capital.
What sectors and investment stages does Accretive target?
Accretive builds companies from the ground up — effectively seed and early-stage creation — across industries undergoing structural change. Its portfolio spans digital health and healthcare services (R1, Accolade, Accumen), online marketplaces and insurtech (Fandango, Insureon), education (Everspring), and enterprise services (Exult, Xchanging). The firm targets industries where a new offering can create a step-change in customer value.
Which sectors does Accretive explicitly avoid?
The firm does not publish a formal exclusions list. Its historical pattern shows no activity in hard-asset infrastructure, natural resources, real estate development, or consumer-packaged goods. The model gravitates toward technology-enabled services, information-intensive industries, and domains where procurement or administrative complexity creates a large addressable market for an outsourced solution.
What is Accretive's known posture on co-investments?
Accretive does not operate a co-investment program for external allocators. It builds companies using its own balance sheet. Once a company is operating, the firm may support it in attracting external growth capital, but that occurs at the portfolio-company level rather than through an Accretive-sponsored co-investment vehicle.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: